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Cochlear implants are a new surgical option in the hearing rehabilitation of patients with neuroﬁbromatosis type 2 (NF2) and
patients with vestibular schwannoma (VS) in the only hearing ear. Auditory brainstem implant (ABI) has been the standard
surgical treatment for these patients. We performed a literature review of patients with NF2 and patients with VS in the only
hearing ear. Cochlear implantation (CI) provided some auditory beneﬁt in all patients. Preservation of cochlear nerve integrity is
crucialafterVSresection.Resultsrangedfromenvironmentalsoundawarenesstoexcellentbeneﬁtwithtelephoneuse.Promontory
stimulation is recommended although not crucial. MRI can be performed safely in cochlear implanted patients.
1.Introduction
1.1. Treatment Approach in Bilateral Hearing Loss. Bilateral
hearing loss represents a great disability for patients with
neuroﬁbromatosis type 2 (NF2) and patients with vestibular
schwannoma (VS) in the only hearing ear. The treatment
for VS patients (unilateral and bilateral) is diverse, including
observation, surgery, and radiotherapy [1].
Treatment of the worst hearing ear in NF2 patients could
leave an only hearing ear with tumor and the risk of further
hearing loss. Moreover, treatment of VS in an only hearing
ear can also lead to deafness. Both situations represent a
therapeutic dilemma [2]. Developments of new hearing
rehabilitation strategies have changed the management of
these patients. Figure 1 shows the MRI of a patient with
bilateral vestibular schwannomas.
1.2. Surgical Options in Hearing Rehabilitation. Since 1979,
auditorybrainstemimplant(ABI)hasbeentheonlyauditory
rehabilitation option in patients with no serviceable hearing
and previous schwannoma resection. ABI was designed
to restore hearing in patients with nonfunctional cochlear
nerves who were not candidates for cochlear implantation
[3]. Although ABI provides environmental sound and signif-
icant lip reading assistance, they have not reached consistent
results in speech discrimination [3–7].
Recently cochlear implants have emerged as a reasonable
therapeutic option in selected cases. Initially patients should
undergo schwannoma resection with preservation of the
cochlear nerve as the main goal. Subsequently CI is done in a
standardfashionthroughacochleostomyordirectlythrough
theroundwindow.ResultsofCIinNF2patientsandVSinan
only hearing ear are quite promising [8–10]an dm a yp r o vi d e
outcomes comparable to those of postlingually implanted
nontumor patients.
In this study we reviewed cochlear implantation as
hearing rehabilitation in patients with NF2 and in patients
with VS in the only hearing ear.
1.3. Cochlear Nerve Preservation and Function. Bilateral
vestibular schwannomas in a NF2 patient can invade and
grow within the cochlear nerve, while unilateral sporadic
vestibular schwannoma (VS) only compresses it [11]. Also,
identiﬁcation of the surgical plane between the tumor and2 International Journal of Otolaryngology
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Figure 1: MRI axial and coronal view of neuroﬁbromatosis type 2 patient.
the cochlear nerve is more demanding on an NF2 patient
than on sporadic VS [11, 12]. Despite the diﬃculty implied
in schwannoma resection, there are reports that demon-
strate cochlear nerve preservation after surgery. Diﬀerent
approachesusedfortumorremovalareretrosigmoid,middle
fossa and translabyrinthine [8–10, 12]. Radiosurgery is also
an option for VS treatment previous to CI [13].
Cochlear nerve function is not always preserved in spite
of anatomic preservation of the cochlear nerve. An intact
nerve does not necessarily mean a normal nerve histolog-
ically [14]. Cochlear nerve can be injured during surgery,
causing intraneural hemorrhage, disruption of axons, espe-
ciallyintheObersteiner-Redlichzone.Amoderateinjurycan
cause hearing loss but still allows electrical transmission of
the stimulus. One way to evaluate function of the nerve is
through electrical promontory stimulation.
1.4. Spiral Ganglion Cells and Deafness. Spiral ganglion cells
are the neural structure stimulated by the cochlear implant,
therefore crucial for cochlear implantation [15].
With deafness there is a loss of hair cells with subsequent
degeneration of spiral ganglion cells [16]. Some authors have
suggested that this is not necessarily true. Teufert et al. [17]
inatemporalbonestudyfromtheHouseClinicstatedthatin
contrast with animal studies spiral ganglion cells can survive
even in the absence of hair cells. They demonstrated that 16
of 33 ears had peripheral processes despite the total absence
of hair cells.
Nadol found [15] in 93 temporal bones of profoundly
deaf people a diminished main spiral ganglion population.
The loss of spiral ganglion cells was greater in older patients,
with longer duration of hearing loss and located in the basal
turn. An association with etiology was also found. Patients
with aminoglycoside toxicity and sudden idiopathic deafness
had the highest spiral ganglion cell counts, whereas patients
with the lowest counts were diagnosed with postnatal viral
labyrinthitis, congenital deafness, or bacterial meningitis.
The authors described 27,304 ± 4,203 spiral ganglion count
in the normal hearing group and 15,463 ± 7,838 in patients
with hearing loss (P = 0.0008).
Fayad et al. published that 3500 intact neurons were
required for a cochlear implant to be successful [18]. Useful
auditorysensationcouldresultfrom10%ofthetotalnumber
of ganglion cells.
There is controversy on the role spiral ganglion cells have
on speech perception [15, 19]. Fayad et al. in 1991 compared
the speech results in single channel implanted patients. No
signiﬁcant correlation was found between the perceptual
scores and ganglion cell numbers [18]. Two patients with
3000 surviving neurons performed similarly more than
patients with 15000 neurons. Blamey [19] also found no
evidence of strong association between speech perception
and ganglion cell number. The authors assumed that the
minimum number of cells required for speech perception
is quite low. A histopathological study [15]d e m o n s t r a t e da
poor correlation between speech performance and number
of ganglion cells.
1.5. Labyrinthectomy and Spiral Ganglion Cells Integrity.
Histological studies in temporal bones with labyrinthectomy
have demonstrated that enough ganglion cells may survive,
proving the feasibility of cochlear implants [20, 21]. Facer
et al. [22] reported a case who underwent labyrinthectomy
and cochlear implantation with beneﬁcial results. Another
temporal bone study [23] examined 8 specimens from
patients who underwent acoustic tumor removal through a
translabyrinthine approach. Because of diﬀerent histological
cochlear modiﬁcations after surgery (e.g.: ossiﬁcation, ﬁbro-
sis), they recommended simultaneous cochlear implantation
for better results.International Journal of Otolaryngology 3
1.6. Cochlear Implantation and Neural Integrity. The eﬀect
of electrical stimulation on residual ganglion cells is also
controversial. Coco et al. [24] showed a signiﬁcant increase
in the soma area of ganglion cells adjacent to the stimulating
electrodes in cats with profound hearing loss and chronic
electrical stimulation. The increased in soma area was
explained as a possible increase in cell biosynthesis. A
signiﬁcant rescue of ganglion cells in middle and apical
turns of stimulated cochlea in animals with partial hearing
was also found [24]. Linthicum et al. [25] demonstrated
no modiﬁcation in spiral ganglion cell population with
prolonged electrical stimulation (up to 14 years).
In the evaluation of trauma to the inner ear by cochlear
implantation, Nadol [15] found damage to the lateral
cochlear wall and basilar membrane in the upper basal turn.
Newboneformationandperielectrodeﬁbrosiswascommon.
Degeneration of the spiral ganglion were not correlated with
cochlear changes.
1.7. Status of the Cochlear Nerve after Hearing Preservation
Techniques. Hearing preservation approaches include mid-
dle fossa and retrosigmoid. In spite of preservation of the
cochlear nerve during surgery, several patients lose hearing
inthepostoperativeperiod.Theoriesthatexplainthisﬁnding
[26] are direct neuronal disruption of the cochlear nerve and
vascular injury to the cochlea. As stated before, promontory
electrical stimulation can be used to assess ganglion cell
survival. An electrical response can be obtained if 10–25% of
spiral ganglion cells are preserved. Cueva et al. [26] studied 6
patients with anacusis following acoustic neuroma surgery.
Only one patient had subjective auditory perception with
EPS. A possible explanation of anacusis in this case was
vascular compromise of the cochlea.
Neﬀ et al. [8] also reported cases with postoperative
hearing loss with hearing preservation techniques in spite
of anatomically preserved cochlear nerve. They suggested
cochlear implantation in these patients even if blood supply
is interrupted as long as electrical promontory stimulation
(EPS) is positive.
Failureofhearingpreservationaftersurgeryhasalsobeen
described by Lustig et al. [9] who included 5 cases with
this situation. Patients with good performance with cochlear
implantation were supposed to have vascular injury and
those with poor performance a signiﬁcant neuronal injury
due to tumor growth or surgical removal. All patients in
this series had some functional improvement with cochlear
implantation, emphasizing that even limited electrical stim-
ulation can oﬀer beneﬁt in these patients.
McKenna et al. [27] did a long-term followup (3.4 to
10.4 years) of patients with VS removal via RS approach.
Four patients (22%) experienced a decline in PTA or SDS,
probably related to vascular compromise or microscopic
recurrence. Neﬀ et al. [8] in contrast, refuted that hearing
deteriorated after a certain postoperative period. This group
reported the largest followup in patients with cochlear
implantation and VS resection available in the literature.
Withameanfollowupof7.9years,inallbutonecase,hearing
results did not deteriorate over time.
2. Methods
We performed a literature review from 1992 to 2010 by
using a comprehensive search strategy in Cochrane library,
MEDLINE, and PubMed databases.
The following search terms were used: neuroﬁbromatosis
type 2, vestibular schwannoma, acoustic neuroma, bilateral
hearing loss, deafness, auditory rehabilitation, auditory brain-
stem implants, radiosurgery, and MRI. The limiting search
terms were cochlear implantation, treatment, and clinical
cases. Additional articles were identiﬁed by hand searching
the references from original and review articles. The search
was restricted to English and Spanish language.
The identiﬁed articles were assessed for eligibility and
only the articles that explored cochlear implantation in
NF2 patients and VS in the only hearing ear were selected.
Only retrospective case series or case reports were available
for review. All patients underwent cochlear implantation
after VS resection and/or radiosurgery. Diverse outcome
assessments were reported.
3. Reported Outcomes in Patients Undergoing
Cochlear Implantation andVS Resection
Various centers have reported their outcomes in cochlear
implantation and vestibular schwannoma resection [8–10,
12, 28–36]. The majority included almost exclusively NF2
patients (see Tables 1–3). Twenty-seven patients were treated
with VS surgery and cochlear implantation and 6 cases with
radiosurgery and cochlear implantation. Age ranged from 15
to 84 years. As expected, the oldest patient was treated with
radiosurgery.
Only two studies reported two cases with unilateral
vestibular schwannoma in the only hearing ear. A slight
better hearing performance could be observed [28]i na
unilateral vestibular schwannoma patient compared to the
performance of an NF2 patient of the same institution
(vowel identiﬁcation 100%, bisyllable word recognition 95%
versus vowel identiﬁcation 80%, bisyllable word recognition
90%, resp.). Another case with VS in the only hearing ear
was published by Arriaga and Marks [10]. This patient
presented with a postoperative PTA of 25dB, the best
reported in the literature. However, no speech tests were
reported. Lip reading with the implant was 50% better than
without the implant with markedly improved recognition of
environmental sounds and communication at home.
Regardless of the time of cochlear implantation or
approach used, the speech perception outcome through the
studies is diverse. It ranges from no beneﬁt to signiﬁcant
better speech discrimination. It is important to point out the
diﬀerent outcomes described in these studies. Some studies
focus on open-set speech perception whereas others report
on closed-set tests. Some tests are assisted by lip reading.
We detail the results in subsequent tables, to be analyzed
separately (Tables 1 and 2).
Lustig et al. [9] reported the most contrasting results.
Three patients who underwent VS resection and cochlear
implantation had 0% in all the speech tests. However, all4 International Journal of Otolaryngology
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patients had environmental sound awareness, sound lo-
calization, and improved performance. The variability of the
performance was explained by the authors, by variations
in the status of the cochlear nerve. Another explanation
was meaning serviceable contralateral hearing. Patients
were assumed to have diﬃculty in integrating input from
a cochlear implant from the deaf ear with contralateral
serviceablehearing.Itisassumedthataspatientslosehearing
in the better ear they should rely more on the implanted side.
In the whole series, fourteen patients were reported to
use the telephone. Most of them belong to the VS resection
group (Table 1). Only one patient (1/6) was described as a
telephone user in the radiosurgery group. This may be due
to the lack of reported data in the radiosurgery patients.
The daily use of the cochlear implant was reported in 16
patients (48%).
There are 7 cases of simultaneous cochlear implanta-
tion and vestibular schwannoma resection. Theoretically, a
prompt implantation will reduce cochlear ﬁbrosis or ossiﬁ-
cation and avoid multiple interventions. Overall, the authors
reported good results compared to their counterparts
(delayed surgery). All patients who underwent simultaneous
implantationhadatranslabyrinthineschwannomaresection.
Vincenti et al. [29] found no cochlear ossiﬁcation within
3 months after TL VS removal. This was the only case of
postponed cochlear implantation in TL surgery. In another
case [28] from another institution, cochlear implantation
was attempted one year after TL surgery. The authors found
total ossiﬁcation and implantation could not be performed.
Due to bilateral hearing loss secondary to NF2, they decided
to resect the contralateral VS with simultaneous CI in that
side, which was performed uneventfully.
Translabyrinthine approach did not aﬀect speech recep-
tion results and outcomes compared with other approaches.
The longest period between surgery and implantation
was 84 months following a retrosigmoid approach, with
reported hearing gain.
The longest followup was done by Neﬀ et al. [8], with an
average of 7.9 years after CI.
3.1. Electrical Promontory Stimulation (EPS). To assess the
status of the cochlear nerve, electrical promontory stim-
ulation is recommended before implanting patients with
VS. Promontory or round window stimulation evaluates the
neurons in the cochlear spiral ganglion. Both anatomically
and functionally preserved cochlear nerves are important
requirements for implantation. However, false negative stim-
ulations have been described if EPS is performed too close
to the surgical event. It is recommended to repeat mea-
surements 6–8 weeks postoperatively, even after a previous
negative measurement [8].
In the literature review we found four cases with
promontory stimulations initially negative and subsequently
positive (Tables 1 and 2). The possible mechanism of this
phenomenon is described by the authors [8, 12, 34]. One
theory states possible surgical damage to the cochlear nerve
with postoperative inﬂammation that subsequently subsides.
Another theory highlights the role of vascular supply to the
cochlear nerve. Vincenti et al. [29] reported a case in which
the EPS was negative, and because cochlear nerve integrity
was certain, they proceeded with the cochlear implant. They
had environmental sound recognition and usefulness lip
reading. Another case with negative EPS was published
by Trotter and Briggs [13] after radiosurgery, the results
showing improved outcome with 72% in CUNY sentences
in quiet and 45% in CNC words.
Cueva et al. [26] reported 6 cases with anacusis following
VS surgery. Only one patient had postoperative positive EPS
suggesting vascular compromise to the cochlea (especially
stria vascularis) with a partially intact cochlear nerve.
The majority of the studies reviewed (Table 1)r e p o r t e d
positive electrophysiological studies consisting of electrical
promontory stimulation (EPS) or compound action poten-
tial (CNAP). Results were recorded simultaneously and up to
84 months postsurgically.
Authors considered the performance of electrophysio-
logical tests an important examination prior to implanta-
tion, although not crucial. Thirteen cases of the present
review did not have data on electrophysiological tests and
were nonetheless submitted to cochlear implantation. These
patients had good auditory beneﬁt. Ar´ ıstegui and Denia [28]
reported one case with 100% in daily words and 100% in
CID. Other cases had no reported EPS or speech tests but
authors reported subjective auditory beneﬁt. In addition to
two cases with negative EPS, a total of 15 cases underwent CI
without objective evidence of cochlear nerve function. This
did not alter their ﬁnal results.
3.2. Comparative Results with Cochlear Implantation in Con-
ventional Postlingually Deaf Adults. The speech tests results
in conventional postlingually deaf adults undergoing con-
ventional CI are similar with all devices manufactured. Good
results in speech discrimination achieved by these patients
are published through the literature [37–42], in general: 80
to 90% in vowel recognition [40], 50–60% in bisyllable
identiﬁcation [40], 70 to 100% in word recognition [41],
65% to 80% in correct sentence recognition scores [37–39],
85% HINT in quiet score, and 65% in HINT in noise score
[42]. Two factors implied in good performance were age at
implantation and duration of deafness.
The House Clinic reported that up to one-third of
postlingual adults undergoing implantation achieve open-
set speech recognition [3]. Poor performers beneﬁt from
environmental sounds awareness and assisted lip reading
skills.
Vincenti et al. [29] highlight the similarity of speech tests
results between CI patients after VS resection compared with
conventional postlingually implanted patients. The larger
case series (Table 1) reported good speech results. Neﬀ et
al. [8] described HINT results ranged from 83 to 96%,
CID between 22–100%. On the other hand, Ar´ ıstegui and
Denia[28]found100%dailywordsrecognitionand100%in
CID in two postimplanted patients with VS resection. Tran
Ba Huy et al. [30] described the results of open sentences
recognition test without lip reading from 81–97%, although
Lustig et al. [9]reportedmorevariableresultswhen3oftheir
patients performed 0% in all speech tests.8 International Journal of Otolaryngology
The best results in speech discrimination achieved by
postimplanted patients with NF2 or patients with VS in the
only hearing ear are comparable with the results obtained by
conventional postlingually deaf adults.
3.3. Comparative Results with ABI. Colletti et al. (2009),
compared open-set speech perception in tumor and non-
tumor patients treated with ABI [7]. They found 10–100%
on open-set speech perception scores in nontumor patients,
compared with 5–31% in tumor patients. This diﬀerence
was statistically signiﬁcant. The authors conclude that ABI
is an eﬀective tool for hearing rehabilitation in patients with
profound hearing loss who cannot be ﬁtted with cochlear
implants (CI).
Grayeli et al. [4] reported open set dyssyllabic word
recognition of 36% for vision only mode, 3% for sound only
mode, and 65% for vision plus sound mode in NF2 patients
with ABI.
In the House Clinic review on ABI, 85% of patients
perceived auditory sensation [3]. Combined with lip reading
cues, 93% of patients improved sentence understanding in 3
to 6 months. Most patients had environmental sound aware-
ness and understanding of closed set words, consonants, and
vowels, while open set speech discrimination was diﬃcult to
achieve. In contrast, Lenarz et al. [6] reported better results
with 2 out of 11 patients achieving some kind of telephone
conversation. In general open set speech recognition in
the auditory mode alone is not common among patients
implanted with ABI [5, 6].
T h eo n l ys t u d yf o u n dt oc o m p a r eA B Iv e r s u sC Ia f t e r
VS resection from the same institution was performed
by Vincenti et al. [29]. They included 9 patients, 4 with
CI and 5 with ABI. At 1-year followup, the performance
in close set was similar. Nonetheless, the open set tests
showed a compelling diﬀerence. Mean common phrases
comprehension score was 60% in the CI group and 29% in
the ABI group. Mean sentence recognition score was 55%
in the CI group and 27% in the ABI patients. Moreover,
mean bisyllabic word recognition score was 53% in the CI
group and 32% in the ABI group. The authors concluded
that when possible the CI should be the preferred hearing
rehabilitation device for patients with VS, not only because
ofthebetterhearingresults,butalsobecauseofthereduction
of the surgical risks and lesser extent of the operation.
As poor speech reception results are prevalent in the ABI
literature, it is recommended to preserve the cochlear nerve
during VS resection in order to achieve better hearing results
with a cochlear implant.
4. Reported Outcomes inPatients
with VS TreatedwithRadiosurgery
andCochlear Implantation
RadiosurgeryisanalternativetosurgeryforpatientswithVS.
This treatment consists in the delivery of ionizing radiation
to the intracranial target with the use of a stereotactic
technique [43, 44].
Irradiation of head and neck tumors without ear involve-
ment has shown to aﬀect ganglion cell population in a
temporal bone study [45]. Marked spiral ganglion loss in
the basal turn of the cochlea was found in the irradiated
group compared with the same area in controls. Bohne et al.
[46] studied in a chinchilla model the eﬀect of fractionated
radiation on the ear. They found degeneration of hair cells,
supporting cells, and cochlear neurons. Guinea pigs also
showed damaged to outer and inner hair cells after fast
neutron irradiation greater than 15Gy [47].
In relation to gamma knife surgery, Linskey et al.
described the radiation exposure of normal temporal bone
structures during gamma knife surgery [48]. A mean of
5.5Gy absorption was found at the inferior portion of the
basal turn of the cochlea and 8.9Gy absorption at the
modiolus of the basal turn. Although doses greater than
12Gy are described as potentially toxic to the inner ear, the
basal turn of the cochlea absorbed doses greater than 12Gy
in 10 to 14% of cases. Additionally a change in PTA was
signiﬁcantly poorer at 12 months for patients whose cochlea
received 4.75Gy or more [49].
Wackym et al. [50] examined 59 patients and found a
hearing loss pattern consistent with stria vascularis devas-
cularization after gamma knife surgery, that is, hearing loss
across all frequencies and relative preservation of speech
discrimination ability. No neural hearing loss was registered.
Based on this data, direct cochlear damage could be the sole
cause of post radiotherapy hearing loss [50]. Furthermore,
they did not ﬁnd a correlation between change in tumor
size after radiotherapy and hearing loss, making tumor
edema a less likely cause. In order to conﬁrm this, more
studiesarerequired,includingtemporalbonehistopathology
examination.
Among series describing cases with cochlear implanta-
tionafterradiationarethoseofLustig,TranBaHuyetal.,and
Trotter and Briggs. Lustig et al. [9]r e p o r t e d2c a s e st r e a t e d
with radiosurgery and then cochlear implantation. These 2
cases had the best speech test results at that same institution
(one patient MTSr 46%, the other SDS 46%, HINT 98%).
The authors did not explain this ﬁnding.
Tran Ba Huy et al. and Trotter and Briggs [13, 30]
reported good results in speech score tests after cochlear
implantation and radiosurgery in 3 more patients. Mean
followup was 32 months with no sign of malignancy until
the end of followup (Table 3).
5. MRI Followup inCochlear
ImplantedPatients
Between the cochlear implant and the MRI there is a mag-
netic ﬁeld interaction. CIs have internal magnets which
interact with magnets contained in the MRI scanner [51].
An important issue in NF2 patients and patients with
resected VS is the necessity of followup with MRI.
ToperformMRI,therearebasically3options:removalof
the magnet before MRI, implantation of magnetless device,
and implementation of low Tesla’s MRI.International Journal of Otolaryngology 9
(a) (b)
Figure 2: MRI followup at 1.5 T of a patient with surgically removed VS and cochlear implantation (Pulsar CI 100, Med-el).
The risks of MRI imaging in patients with the magnet
device in place include potential device displacement, over-
heating of the surrounding tissues, demagnetization of the
device, and cochlear implant malfunction.
CI magnets described to be removable by a surgical
procedureareCochlearCorporationCI24M,CI24R,Nucleus
Freedom, CI24ABI devices, and Advanced Bionics HiRes90K
[51]. This option requires two minor surgical procedures,
one to remove the magnet and another to replace it.
Current US FDA guidelines have approved the use of 0.2
to 1.5 Teslas with the magnet in place in pulsar and sonata
MED-EL Corp [51] .U n f o r t u n a t e l y ,0 . 2o rl o w e rt h a n1 . 0
Tesla MRI is not available in most hospitals, while 1.5 Tesla is
becoming more universally used. Ex vivo and in vivo studies
recommend the use of 1.5 Teslas for a safe MRI scan in
patients with cochlear implant [52, 53].
Baumgartner et al. [54] published the results of 30
cochlear implants undergoing 1.0 Tesla MRI examination.
No adverse eﬀects were reported. They recommended scan-
ning Med El Combi 40 and Nucleus mini 22 series at 1 Tesla
as a safe procedure, magnet removal being not necessary.
During a 1.5 Tesla MRI scan, the device is subject to
forces that can potentially cause its movement. The force
described with the magnet removed is 0.03N in a 1.5 Tesla
MRI. On the other hand, with the magnet in place the force
is 0.42 N. However, the force described to fracture the CI
receiver bed was much higher than that generated by a 1.5
Tesla MRI [52].
Deneuve et al. [55] reported a case of magnet displace-
ment during 1.5 T MRI. Interestingly, the authors took all
precautions and had an external ﬁxation dressing at the time
of the MRI. Other authors suggest that previous surgery to
remove and replace the magnet in this patient may have
weakened the pocket [52].
Heating of the CI during 1.5 Tesla MRI is reported to be
lower than 0.1◦C[ 52] and the electrical stimulation is less
than the intensity required for auditory stimulation. In an ex
vivo study, a temperature lower than 1.0◦C was measured in
a 3.0 Tesla MRI. A maximum temperature of 2.0◦Ci ss e tb y
theindustrystandardasthetemperaturethatcandamagethe
tissues and cause patient discomfort [51].
Cadaver studies have shown no important demagneti-
zation of the CI during 1.5 Tesla MRI [51]. The use of
compression dressings is recommended for external ﬁxation
of the CI [52].
The magnetic ﬁeld interactions depend on geometric
orientation of the poles. Majdani et al. [51]r e p o r t e d
that demagnetization depends on the angle between the
magnetic ﬁeld of the CI magnet and the MRI. Important
demagnetization happened if this angle was greater than 80
degrees. Thus, excessive head turning is to be avoided during
MRI scan.
Another issue to consider is the image quality obtained
from the MRI scan. While in the contralateral side of the
cranium and remainder of the body, the image has no
distortion; ipsilateral soft tissues within 7 to 8cm from the
magnetarepoorlyvisualized[52].Someauthorsrecommend
combining MRI with high resolution CT with contrast to
counterweigh the area of image distortion.
An ex vivo study performed MRI tests (1.5 Tesla and 0.3
Tesla) to a Clarion 1.2 magnet-containing cochlear implant.
The area of distortion had a radius of 60mm in the 1.5 Tesla
MRI group and 100mm in the 0.3 Tesla group. There was no
detectable temperature increase in both groups [56].
Furthermore, a retrospective study by the John Hopkins
University included 16 patients with CI from 3 major
manufactures. All patients underwent 1.5 Tesla MRI. They
reported an artifact on brain MRI with a maximal anterior-
posterior dimension of 6.6cm and a lateral dimension of
4.8cm around the magnet device with no diﬀerence among
the 3 CI manufacturers. The contralateral internal auditory
canal was seen in all patients and the ipsilateral internal10 International Journal of Otolaryngology
auditorycanalwasatleastpartlyvisibleinallbutonepatient.
No magnet displacement was observed. They recommended
the use of 1.5 Teslas MRI in CI patients [52]. On the other
hand, Baumgartner et al. in a 1.0 Tesla MRI setting reported
minimal artifact although they provided no artifact area
measurements and it was not clear whether the ipsilateral
IAC was evident on MRI [54]. See Figure 2 for an example
of MRI followup in an implanted patient.
A safe use of 1.5 T MRI is recommended for cochlear
implant patients. In patients with NF2 and VS, ipsilateral
MRI control can be accomplished with adjuvant CT with
contrast, and an artifact around 5cm should be expected.
Contralateral surveillance is achieved with no image distor-
tions.
6. Conclusions
Cochlear implantation in patients with neuroﬁbromatosis
type 2 and patients with vestibular schwannoma in the only
hearing ear is a reasonable hearing rehabilitation option.
Early surgical intervention with preservation of the cochlear
nerveshouldbeconsidered.Auditorybeneﬁtcanbeexpected
in most patients, and in good candidates excellent beneﬁt
with good speech discrimination and telephone use may
be achieved. Surgical resection through translabyrinthine
approach does not aﬀect speech test outcomes. Radiosurgery
has good auditory results. Although not crucial, promontory
stimulation for evaluating the integrity of the cochlear nerve
is recommended. MRI up to 1.5 Teslas with external head
ﬁxation can be done safely in cochlear implanted patients.
References
[1] W. Slattery and L. Fisher, “Neuroﬁbromatosis type 2,” in
Neurotology, R. Jackler and D. Brackman, Eds., pp. 783–791,
Elsevier, USA, 2005.
[2] C. L. W. Driscoll, R. K. Jackler, L. H. Pitts, and D. E. Brack-
mann, “Lesions of the internal auditory canal and cere-
bellopontine angle in an only hearing ear: is surgery ever
advisable?” American Journal of Otology, vol. 21, no. 4, pp.
573–581, 2000.
[ 3 ]E .H .T o ha n dW .M .L u x f o r d ,“ C o c h l e a ra n dB r a i n s t e m
Implantation,” Neurosurgery Clinics of North America, vol. 19,
no. 2, pp. 317–329, 2008.
[4] A.B.Grayeli,M.Kalamarides,D.Bouccara,E.Ambert-Dahan,
and O. Sterkers, “Auditory brainstem implant in neuroﬁbro-
matosis type 2 and non-neuroﬁbromatosis type 2 patients,”
Otology & Neurotology, vol. 29, no. 8, pp. 1140–1146, 2008.
[5] T.Lenarz,M.Moshreﬁ,C.Matthiesetal.,“Auditorybrainstem
implant. Part I. Auditory performance and its evolution over
time,” Otology and Neurotology, vol. 22, no. 6, pp. 823–833,
2001.
[6] M. Lenarz, C. Matthies, A. Lesinski-Schiedat et al., “Auditory
brainstem implant part II: subjective assessment of functional
outcome,” Otology and Neurotology, vol. 23, no. 5, pp. 694–
697, 2002.
[7] V .Colletti,R.Shannon,M.Carner ,S.V eronese,andL.Colletti,
“Outcomes in nontumor adults ﬁtted with the auditory brain-
stem implant: 10 years’ experience,” Otology and Neurotology,
vol. 30, no. 5, pp. 614–618, 2009.
[8] B. A. Neﬀ, R. M. Wiet, J. M. Lasak et al., “Cochlear im-
plantation in the neuroﬁbromatosis type 2 patient: long-term
follow-up,” Laryngoscope,vol.117,no.6,pp.1069–1072, 2007.
[ 9 ] L .R .L u s t i g ,J .Y e a g l e ,C .L .W .D r i s c o l l ,N .B l e v i n s ,H .F r a n c i s ,
and J. K. Niparko, “Cochlear implantation in patients with
neuroﬁbromatosis type 2 and bilateral vestibular schwan-
noma,” Otology and Neurotology, vol. 27, no. 4, pp. 512–518,
2006.
[10] M.A.ArriagaandS.Marks,“Simultaneouscochlearimplanta-
tion and acoustic neuroma resection: imaging considerations,
technique, and functional outcome,” Otolaryngology—Head
and Neck Surgery, vol. 112, no. 2, pp. 325–328, 1995.
[11] F. H. Linthicum and D. E. Brackmann, “Bilateral acoustic
tumors. A diagnostic and surgical challenge,” Archives of
Otolaryngology, vol. 106, no. 12, pp. 729–733, 1980.
[12] R. A. Hoﬀman, D. Kohan, and N. L. Cohen, “Cochlear im-
plants in the management of bilateral acoustic neuromas,”
American Journal of Otology, vol. 13, no. 6, pp. 525–528, 1992.
[13] M. I. Trotter and R. J. S. Briggs, “Cochlear implantation in
neuroﬁbromatosis type 2 after radiation therapy,” Otology and
Neurotology, vol. 31, no. 2, pp. 216–219, 2010.
[14] P.R.Lambert,R.A.Ruth,andJ.F.Thomas,“Promontoryelec-
trical stimulation in postoperative acoustic tumor patients,”
Laryngoscope, vol. 102, no. 7, pp. 814–819, 1992.
[15] J. B. Nadol, “Patterns of neural degeneration in the human
cochlea and auditory nerve: Implications for cochlear implan-
tation,” Otolaryngology—Head and Neck Surgery, vol. 117, no.
3, pp. 220–228, 1997.
[16] G. Clark, “Surgical pathology,” in Cochlear Implants Funda-
mentals and Application, G. Clark, Ed., pp. 100–159, Springer,
USA, 2003.
[17] K. B. Teufert, F. H. Linthicum, and S. S. Connell, “The eﬀect
of organ of Corti loss on ganglion cell survival in humans,”
Otology and Neurotology, vol. 27, no. 8, pp. 1146–1151, 2006.
[18] J. Fayad, F. H. Linthicum, F. R. Galey, S. R. Otto, and W. F.
House,“Cochlearimplants:histopathologicﬁndingsrelatedto
performance in 16 human temporal bones,” Annals of Otology,
RhinologyandLaryngology,vol.100,no.10,pp.807–811,1991.
[19] P. Blamey, “Are spiral ganglion cell numbers important for
speech perception with a cochlear implant?” American Journal
of Otology, vol. 18, no. 6, pp. S11–S12, 1997.
[20] D. A. Chen, F. H. Linthicum, and F. M. Rizer, “Cochlear
histopathology in the labyrinthectomized ear: implications
for cochlear implantation,” Laryngoscope, vol. 98, no. 11, pp.
1170–1172, 1988.
[21] J. L. Kemink, P. R. Kileny, J. K. Niparko, and S. A. Telian,
“Electrical stimulation of the auditory system after lab-
yrinthectomy,” American Journal of Otology,v o l .1 2 ,n o .1 ,p p .
7–10, 1991.
[22] G. W. Facer, M. L. Facer, C. M. Facer Fowler, R. H. Brey, and A.
M. Peterson, “Cochlear implantation after labyrinthectomy,”
American Journal of Otology, vol. 21, no. 3, pp. 336–340, 2000.
[23] A. Belal, “Is cochlear implantation possible after acoustic
tumor removal?” Otology and Neurotology,v o l .2 2 ,n o .4 ,p p .
497–500, 2001.
[ 2 4 ]A .C o c o ,S .B .E p p ,J .B .F a l l o n ,J .X u ,R .E .M i l l a r d ,a n d
R. K. Shepherd, “Does cochlear implantation and electrical
stimulation aﬀect residual hair cells and spiral ganglion
neurons?”HearingResearch,vol.225,no.1-2,pp.60–70,2007.
[25] F. H. Linthicum, J. Fayad, S. R. Otto, F. R. Galey, and W. F.
House, “Cochlear implant histopathology,” American Journal
of Otology, vol. 12, no. 4, pp. 245–311, 1991.
[26] R. A. Cueva, B. A. Thedinger, J. P. Harris, and M. E. Glasscock,
“Electrical promontory stimulation in patients with intactInternational Journal of Otolaryngology 11
cochlear nerve and anacusis following acoustic neuroma
surgery,” Laryngoscope, vol. 102, no. 11, pp. 1220–1224, 1992.
[27] M. J. McKenna, C. Halpin, R. G. Ojemann et al., “Long-
term hearing results in patients after surgical removal of
acoustic tumors with hearing preservation,” American Journal
of Otology, vol. 13, no. 2, pp. 134–136, 1992.
[28] M. Ar´ ıstegui and A. Denia, “Simultaneous cochlear implanta-
tion and translabyrinthine removal of vestibular schwannoma
in an only hearing ear: report of two cases (neuroﬁbromatosis
type 2 and unilateral vestibular schwannoma),” Otology and
Neurotology, vol. 26, no. 2, pp. 205–210, 2005.
[29] V. Vincenti, E. Pasanisi, M. Guida, G. Di Trapani, and M.
Sanna, “Hearing rehabilitation in neuroﬁbromatosis type 2
patients: cochlear versus auditory brainstem implantation,”
Audiology and Neurotology, vol. 13, no. 4, pp. 273–280, 2008.
[ 3 0 ]P .T r a nB aH u y ,R .K a n i a ,B .F r a c h e t ,C .P o n c e t ,a n dM .
S. Legac, “Auditory rehabilitation with cochlear implanta-
tion in patients with neuroﬁbromatosis type 2,” Acta Oto-
Laryngologica, vol. 129, no. 9, pp. 971–975, 2009.
[31] G. F. Hulka, E. J. Bernard, and H. C. Pillsbury, “Cochlear
implantation in a patient after removal of an acoustic
neuroma: the implications of magnetic resonance imag-
ing with gadolinium on patient management,” Archives of
Otolaryngology—Head and Neck Surgery, vol. 121, no. 4, pp.
465–468, 1995.
[32] T. Tono, Y. Ushisako, and T. Morimitsu, “Cochlear implan-
tation in an intralabyrinthine acoustic neuroma patient after
resection of an intracanalicular tumour,” Journal of Laryngol-
ogy and Otology, vol. 110, no. 6, pp. 570–573, 1996.
[33] R. H. Temple, P. R. Axon, R. T. Ramsden, N. Keles, K. Deger,
and E. Y¨ ucel, “Auditory rehabilitation in neuroﬁbromatosis
type 2: a case for cochlear implantation,” Journal of Laryngol-
ogy and Otology, vol. 113, no. 2, pp. 161–163, 1999.
[ 3 4 ]J .G r a h a m ,C .L y n c h ,B .W e b e r ,L .S t o l l w e r c k ,J .W e i ,a n dG .
Brookes, “The magnetless Clarion cochlear implant in a
patient with neuroﬁbromatosis 2,” Journal of Laryngology and
Otology, vol. 113, no. 5, pp. 458–463, 1999.
[35] S. Ahsan, F. Telischi, A. Hodges, and T. Balkany, “Cochlear
implantation concurrent with translabyrinthine acoustic neu-
roma resection,” Laryngoscope, vol. 113, no. 3, pp. 472–474,
2003.
[36] C. N¨ olle, I. Todt, D. Basta, A. Unterberg, V. F. Mautner,
and A. Ernst, “Cochlear implantation after acoustic tumour
resection in neuroﬁbromatosis type 2: impact of intra- and
postoperative neural response telemetry monitoring,” ORL,
vol. 65, no. 4, pp. 230–234, 2003.
[37] W. Luxford and D. Mills, “Cochlear implantation in adults,” in
Neurotology, R.Jackler and D. Brackman, Eds., pp. 1309–1314,
Elsevier, USA, 2005.
[38] S. Staller, C. Menapace, E. Domico et al., “Speech per-
ception abilities of adult and pediatric nucleus implant
recipients using the spectral peak (SPEAK) coding strategy,”
Otolaryngology—Head and Neck Surgery, vol. 117, no. 3, pp.
236–242, 1997.
[39] R. A. Schindler, D. K. Kessler, and M. Barker, “Clarion patient
performance: an update on the clinical trials,” Annals of
Otology, Rhinology and Laryngology, vol. 104, no. 9, pp. 269–
272, 1995.
[40] M. Manrique, A. Ramos, C. Morera et al., “Analysis of the
cochlear implant as a treatment technique for profound
hearing loss in pre and postlocutive patients,” Acta Otorrino-
laringologica Espanola, vol. 57, no. 1, pp. 2–23, 2006.
[41] K. Strelnikov, J. Rouger, E. Eter et al., “Binaural stimulation
through cochlear implants in postlingual deafness: a positron
emission tomographic study of word recognition,” Otology
and Neurotology, vol. 32, no. 8, pp. 1210–1217, 2011.
[42] R. E. Roditi, S. F. Poissant, E. M. Bero, and D. J. Lee, “A
predictive model of cochlear implant performance in postlin-
gually deafened adults,” Otology and Neurotology, vol. 30, no.
4, pp. 449–454, 2009.
[43] I. Likhterov, R. M. Allbright, and S. H. Selesnick, “LINAC
radiosurgery and radiotherapy treatment of acoustic neuro-
mas,” Neurosurgery Clinics of North America, vol. 19, no. 2, pp.
345–365, 2008.
[44] J. M. Lasak, D. Klish, T. C. Kryzer, C. Hearn, J. P. Gorecki,
and G. P. Rine, “Gamma knife radiosurgery for vestibular
schwannoma: early hearing outcomes and evaluation of the
cochleardose,”Otology&Neurotology,vol.29,no.8,pp.1179–
1186, 2008.
[45] D. L. Hoistad, F. G. Ondrey, C. Mutlu, P. A. Schachern, M.
M. Paparella, and G. L. Adams, “Histopathology of human
temporal bone after cis-platinum, radiation, or both,” Oto-
laryngology—Head and Neck Surgery, vol. 118, no. 6, pp. 825–
832, 1998.
[46] B. A. Bohne, J. E. Marks, and G. P. Glasgow, “Delayed eﬀects
of ionizing radiation on the ear,” Laryngoscope, vol. 95, no. 7,
pp. 818–828, 1985.
[47] C. S. Kim and S. O. Shin, “Ultrastructural changes in the
cochlea of the guinea pig after fast neutron irradiation,”
Otolaryngology—Head and Neck Surgery, vol. 110, no. 4, pp.
419–427, 1994.
[48] M. E. Linskey, P. A. S. Johnstone, M. O’Leary, and S. Goetsch,
“Radiation exposure of normal temporal bone structures dur-
ing stereotactically guided gamma knife surgery for vestibular
schwannomas,” Journal of Neurosurgery,v o l .9 8 ,n o .4 ,p p .
800–806, 2003.
[49] J. M. Lasak, D. Klish, T. C. Kryzer, C. Hearn, J. P. Gorecki,
and G. P. Rine, “Gamma knife radiosurgery for vestibular
schwannoma: early hearing outcomes and evaluation of the
cochleardose,”Otology&Neurotology,vol.29,no.8,pp.1179–
1186, 2008.
[50] P. A. Wackym, C. L. Runge-Samuelson, J. J. Nash et al.,
“Gammaknifesurgeryofvestibularschwannomas:volumetric
dosimetry correlations to hearing loss suggest stria vascularis
devascularization as the mechanism of early hearing loss,”
Otology and Neurotology, vol. 31, no. 9, pp. 1480–1487, 2010.
[51] O. Majdani, M. Leinung, T. Rau et al., “Demagnetization
of cochlear implants and temperature changes in 3.0T MRI
environment,” Otolaryngology—Head and Neck Surgery, vol.
139, no. 6, pp. 833–839, 2008.
[52] B. T. Crane, B. Gottschalk, M. Kraut, N. Aygun, and J. K.
Niparko, “Magnetic resonance imaging at 1.5 T after cochlear
implantation,” Otology and Neurotology,v o l .3 1 ,n o .8 ,p p .
1215–1220, 2010.
[53] S. P. Gubbels and S. O. McMenomey, “Safety study of the
Cochlear Nucleus 24 device with internal magnet in the 1.5
Tesla magnetic resonance imaging scanner,” Laryngoscope, vol.
116, no. 6, pp. 865–871, 2006.
[54] W. D. Baumgartner, S. Youssefzadeh, J. Hamzavi, C. Czerny,
and W. Gstoettner, “Clinical application of magnetic reso-
nance imaging in 30 cochlear implant patients,” Otology and
Neurotology, vol. 22, no. 6, pp. 818–822, 2001.
[55] S. Deneuve, N. Loundon, N. Leboulanger, I. Rouillon, and E.
N. Garabedian, “Cochlear implant magnet displacement dur-
ing magnetic resonance imaging,” Otology and Neurotology,
vol. 29, no. 6, pp. 789–790, 2008.12 International Journal of Otolaryngology
[56] B. P. Weber, J. E. Goldring, T. Santogrossi et al., “Magnetic
resonance imaging compatibility testing of the Clarion 1.2
cochlear implant,” American Journal of Otology, vol. 19, no. 5,
pp. 584–590, 1998.